Investigation of the Safety of Intranasal Glulisine in Down Syndrome
Clinical trial NCT02432716 · COMPLETED
Trial details
- NCT number
- NCT02432716
- Sponsor
- HealthPartners Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2018-10-18
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.